Tieu, J, Cheah, J T L, Black, R J, Christensen, R, Ghosh, N, Richards, P, Robson, J, Shea, B, Simon, L S, Singhi, J A, Tugwell, P, Boers, M, Garibay, M A A, Campochiaro, C, Decary, S, de Witt, M, Fernandez, A P, Keen, H I, King, L, Hinojosa-Azaola, A, Hofstetter, C, Gaydukova, I, George, M D, Gupta, L, Lyne, S, Makol, A, Mukhtyar, C, Oo, W M, Petri, M, Pisaniello, H L, Sattui, S E, Russell, O, Teixeira, V, Toupin-April, K, Uhunmwangho, C, Whitstock, M, Yip, K, Mackie, S L, Goodman, S M & Hill, C L 2021, ' Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective : The OMERACT glucocorticoid core domain set ', Seminars in Arthritis and Rheumatism, vol. 51, no. 5, pp. 1139-1145 . https://doi.org/10.1016/j.semarthrit.2021.06.010, https://doi.org/10.1016/j.semarthrit.2021.06.010 Tieu, J, Cheah, J TL, Black, R J, Christensen, R, Ghosh, N, Richards, P, Robson, J, Shea, B, Simon, L S, Singhi, J A, Tugwell, P, Boers, M, Garibay, M A A, Campochiaro, C, Decary, S, de Witt, M, Fernandez, A P, Keen, H I, King, L, Hinojosa-Azaola, A, Hofstetter, C, Gaydukova, I, George, M D, Gupta, L, Lyne, S, Makol, A, Mukhtyar, C, Oo, W M, Petri, M, Pisaniello, H L, Sattui, S E, Russell, O, Teixeira, V, Toupin-April, K, Uhunmwangho, C, Whitstock, M, Yip, K, Mackie, S L, Goodman, S M & Hill, C L 2021, ' Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective : The OMERACT glucocorticoid core domain set ', Seminars in Arthritis and Rheumatism, vol. 51, no. 5, pp. 1139-1145 . https://doi.org/10.1016/j.semarthrit.2021.06.010 Seminars in Arthritis and Rheumatism, 51(5), 1139-1145. W.B. Saunders Ltd
Schäfer, V S, Chrysidis, S, Schmidt, W A, Duftner, C, Iagnocco, A, Bruyn, G A, Carrara, G, De Miguel, E, Diamantopoulos, A P, Nielsen, B D, Fredberg, U, Hartung, W, Hanova, P, Hansen, I T, Hocevar, A, Juche, A, Kermani, T A, Lorenzen, T, Macchioni, P, Milchert, M, Døhn, U M, Mukhtyar, C, Monti, S, Ponte, C, Seitz, L, Scirè, C A, Terslev, L, Dasgupta, B, Keen, H I, Pineda, C & Dejaco, C 2021, ' OMERACT definition and reliability assessment of chronic ultrasound lesions of the axillary artery in giant cell arteritis ', Seminars in Arthritis and Rheumatism, vol. 51, no. 4, pp. 951-956 . https://doi.org/10.1016/j.semarthrit.2021.04.014 Schäfer, V S, Chrysidis, S, Schmidt, W A, Duftner, C, Iagnocco, A, Bruyn, G A, Carrara, G, De Miguel, E, Diamantopoulos, A P, Nielsen, B D, Fredberg, U, Hartung, W, Hanova, P, Hansen, I T, Hocevar, A, Juche, A, Kermani, T A, Lorenzen, T, Macchioni, P, Milchert, M, Døhn, U M, Mukhtyar, C, Monti, S, Ponte, C, Scirè, C A, Terslev, L, Dasgupta, B, Keen, H I, Pineda, C & Dejaco, C 2021, ' OMERACT definition and reliability assessment of chronic ultrasound lesions of the axillary artery in giant cell arteritis ', Seminars in Arthritis and Rheumatism, vol. 51, no. 4, pp. 951-956 . https://doi.org/10.1016/j.semarthrit.2021.04.014
Annals of the Rheumatic Diseases, 81(6):221733, 768-779. BMJ Publishing Group Drosos, G C, Vedder, D, Houben, E, Boekel, L, Atzeni, F, Badreh, S, Boumpas, D T, Brodin, N, Bruce, I N, González-Gay, M Á, Jacobsen, S, Kerekes, G, Marchiori, F, Mukhtyar, C, Ramos-Casals, M, Sattar, N, Schreiber, K, Sciascia, S, Svenungsson, E, Szekanecz, Z, Tausche, A K, Tyndall, A, van Halm, V, Voskuyl, A, Macfarlane, G J, Ward, M M, Nurmohamed, M T & Tektonidou, M G 2022, ' EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome ', Annals of the Rheumatic Diseases, vol. 81, no. 6, pp. 768-779 . https://doi.org/10.1136/annrheumdis-2021-221733 Drosos, G C, Vedder, D, Houben, E, Boekel, L, Atzeni, F, Badreh, S, Boumpas, D T, Brodin, N, Bruce, I N, González-Gay, M Á, Jacobsen, S R, Kerekes, G, Marchiori, F, Mukhtyar, C, Ramos-Casals, M, Sattar, N, Schreiber, K, Sciascia, S, Svenungsson, E, Szekanecz, Z, Tausche, A-K, Tyndall, A, van Halm, V, Voskuyl, A, Macfarlane, G J, Ward, M M, Nurmohamed, M T & Tektonidou, M G 2022, ' EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome ', Annals of the Rheumatic Diseases, vol. 81, no. 6, 221733, pp. 768-779 . https://doi.org/10.1136/annrheumdis-2021-221733